LAM
MEDP icon

Lebenthal Asset Management’s Medpace MEDP Stock Holding History

Lebenthal Asset Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-210
Closed -$6K – 523
2016
Q3 		$6K Buy
+210
New +$6.13K ﹤0.01% 817

Other funds holding MEDP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
FA
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Lebenthal Asset Management's MEDP Position: Q4 2016 in Review

Lebenthal Asset Management sold out of Medpace (MEDP) in Q4 2016, closing a stake of 210 shares — an estimated $6K sold.

Lebenthal Asset Management first reported a position in MEDP in Q3 2016 and held it in 1 quarter. The position peaked at $6K in Q3 2016. 79 funds tracked by Wall St. Rank hold MEDP as of Q4 2016.

  • Lebenthal Asset Management reported no remaining Medpace position as of Q4 2016 after selling out during the quarter.
  • Lebenthal Asset Management sold 210 Medpace shares in Q4 2016, an estimated $6K.
  • Lebenthal Asset Management first reported a position in Medpace in Q3 2016 and held it in 1 quarter.
  • Lebenthal Asset Management's Medpace position peaked at $6K in Q3 2016.
  • 79 funds tracked by Wall St. Rank held Medpace as of Q4 2016.

Based on Lebenthal Asset Management's 13F filing for Q4 2016, filed 15 Feb 2017.